Iterum Therapeutics plc (ITRMF) Other financing activities (2018 - 2023)

Iterum Therapeutics has reported Other financing activities for 5 years, with the latest figure at $235000.0 in Q1 2023.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $235000.0 in Q1 2023; TTM through Mar 2023 was $1.3 million, a N/A change from a year earlier, with the FY2022 full-year figure at $433000.0, down 99.52% from the prior year.
• Other financing activities was $235000.0 for Q1 2023 at Iterum Therapeutics, up from -$5000.0 in the prior quarter.
• The five-year high for Other financing activities was $88.6 million in Q1 2021, with the low at -$43.1 million in Q2 2020.
• Average Other financing activities over 4 years is $10.7 million, with a median of $1.0 million recorded in 2021.
• The largest YoY upside for Other financing activities was 96681.63% in 2020 against a maximum downside of 431050.0% in 2020.
• Over 4 years, Other financing activities stood at $3.0 million in 2019, then soared by 449.56% to $16.4 million in 2020, then plunged by 100.03% to -$5000.0 in 2021, then surged by 4800.0% to $235000.0 in 2023.
• The last three Other financing activities figures came in at $235000.0 (Q1 2023), -$5000.0 (Q3 2021), and $1.0 million (Q2 2021), per Business Quant data.